An intervention study of Orff-music therapy for long-term hospitalized patients with schizophrenia
Journal Title: Chinese Journal of Nervous and Mental Diseases - Year 2024, Vol 50, Issue 3
Abstract
[Objective] This research aims to investigate the impact of Orff music therapy on long-term schizophrenic patients in hospitals. [Methods] The study was a randomized, single-blind controlled trial conducted from April,2023 to September,2023. From April to September 2023, sixty-eight individuals diagnosed with persistent schizophrenia were enrolled and evenly distributed into a pair of cohorts: a treatment group of thirty-four people receiving the intervention, and an equal number forming the control group for comparative purposes. Individuals enrolled in the experimental arm of the study were administered Orff-music therapy alongside routine rehabilitation treatment across a span of two months. For a period of 8 weeks, the control group was given only standard rehabilitation treatment, whereas the research group underwent Orff-music therapy in addition to the standard rehabilitation treatment. [Results] Before treatment, there were no significant differences in the positive and negative symptoms scale (PANSS), the inpatient psychosis rehabilitation observe scale (IPROS) and the personal and social performance scale (psp) between two groups. After intervention, the PANSS showed that the changes were better in the study group than in the control group in 3 indicators: negative symptoms (-3.20±4.13 vs. -0.17±2.43, P<0.001), general symptoms (-2.79±3.83 vs. -0.17±2.99, P=0.003) and the total scores (-5.88±6.36 vs. 0.00±4.08, P<0.001), but not in positive symptoms (P>0.05).The IPROS showed that the performances of patients in the study group were better than the control group in terms of participation in work therapy (-0.82±2.08 vs. 0.23±2.10, P=0.041), socialization (-0.59±1.94 vs.0.53±1.69, P=0.014) and ability to live (-0.94±2.50 vs. 0.15±1.48, P=0.033), the changes in scores before and after the intervention were significantly different when compared to the control group. The PSP showed that the changes in scores before and after the treatment of the study group was better than the control group in terms of social activity [0 (-1, 0) vs. 0 (0, 0), P=0.011], and self-care [0 (-1, 0) vs. 0 (-0.25, 0), P=0.012] were better than the control group. [Conclusion] For long-term hospitalized patients with chronic schizophrenia. Orff-music therapy can be a powerful tool for alleviating mental issues, fostering social functioning, and enhancing rehabilitation results.
Authors and Affiliations
Tianle WANG, Rizhao LI, Qiyang HUANG, Daming LIU, Dakai XIA, Ting FENG, Aroufujiang YIERXIATI, Jieyi WU, Bin SUN, Xinyan ZHENG, Yingchun. DAI
Keywords
Related Articles
- EP ID EP750455
- DOI 10.3969/j.issn.1002-0152.2024.03.002
- Views 39
- Downloads 0
Chinese experts consensus on chemotherapy for glioma
Glioma is the most prevalent primary intracranial malignant tumor. At present, the main therapy is surgical resection, supplemented by radiotherapy and chemotherapy. Clinical practice has demonstrated that chemotherapy i...
A progress in neuroimaging research on the central mechanisms of botulinum toxin in the treatment of focal dystonia
Botulinum toxin (BoNT) is currently the first-line method for treating focal dystonia, which causes muscle paralysis by chemical denervation. Recent neuroimaging studies have found that BoNT treatment could alter neuropl...
Research progress on the relationship between attention deficit and hyperactive disorder and inflammation
The pathogenesis of attention deficit and hyperactive disorder (ADHD) remains unclear. Evidence from epidemiological, biomarker, and genetic studies indicates that inflammation may play a crucial role in ADHD development...
a case of paraneoplastic cerebellar ataxia syndrome associated with immunocheckpoint inhibitor treated with Ofatumumab
A case of paraneoplastic cerebellar ataxia syndrome caused by immune checkpoint inhibitors (ICI) was treated with ofatumumab (OFA). The patient is a 57-year-old male. He used “Camrelizumab” immunotherapy for his previous...
Research progress on multiple mechanisms underlying visual hallucinations in schizophrenia patients
Visual hallucination (VH) is a common symptom of schizophrenia, the underlying mechanism has not been fully elucidated. It has been found that the dysfunction of dopamine (DA) system, the overactivation of α-amino-3-hydr...